{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:45:43Z","timestamp":1790880343745,"version":"4.1.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"crossref","award":["LZ22H160008"],"award-info":[{"award-number":["LZ22H160008"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96683-3","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:41:51Z","timestamp":1745307711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multi-omics analysis constructs a novel neuroendocrine prostate cancer classifier and classification system"],"prefix":"10.1038","volume":"15","author":[{"given":"Junxiao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuke","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"6","key":"96683_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"96683_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122653","author":"G Aurilio","year":"2020","unstructured":"Aurilio, G. et al. Androgen receptor signaling pathway in prostate cancer: From genetics to clinical applications. Cells https:\/\/doi.org\/10.3390\/cells9122653 (2020).","journal-title":"Cells"},{"issue":"3","key":"96683_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1210\/endrev\/bnab002","volume":"42","author":"K Desai","year":"2021","unstructured":"Desai, K., McManus, J. M. & Sharifi, N. Hormonal therapy for prostate cancer. Endocr. Rev. 42(3), 354\u2013373 (2021).","journal-title":"Endocr. Rev."},{"issue":"Pt 3","key":"96683_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.semcancer.2022.05.007","volume":"86","author":"S Liu","year":"2022","unstructured":"Liu, S., Alabi, B. R., Yin, Q. & Stoyanova, T. Molecular mechanisms underlying the development of neuroendocrine prostate cancer. Semin. Cancer Biol. 86(Pt 3), 57\u201368 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"96683_CR5","doi-asserted-by":"publisher","first-page":"175883592412696","DOI":"10.1177\/17588359241269676","volume":"16","author":"X Fei","year":"2024","unstructured":"Fei, X. et al. Promising therapy for neuroendocrine prostate cancer: Current status and future directions. Ther. Adv. Med. Oncol. 16, 17588359241269676 (2024).","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"10","key":"96683_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41585-021-00490-0","volume":"18","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Molecular events in neuroendocrine prostate cancer development. Nat. Rev. Urol. 18(10), 581\u2013596 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"96683_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-024-2770-x","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Advances and applications in single-cell and spatial genomics. Sci. China Life Sci. https:\/\/doi.org\/10.1007\/s11427-024-2770-x (2024).","journal-title":"Sci. China Life Sci."},{"key":"96683_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105458","volume":"145","author":"M Shehab","year":"2022","unstructured":"Shehab, M. et al. Machine learning in medical applications: A review of state-of-the-art methods. Comput. Biol. Med. 145, 105458 (2022).","journal-title":"Comput. Biol. Med."},{"issue":"12","key":"96683_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110132","volume":"37","author":"ZK Tuong","year":"2021","unstructured":"Tuong, Z. K. et al. Resolving the immune landscape of human prostate at a single-cell level in health and cancer. Cell Rep. 37(12), 110132 (2021).","journal-title":"Cell Rep."},{"issue":"1","key":"96683_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","volume":"23","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Single-cell analysis reveals transcriptomic remodelings in distinct cell types that contribute to human prostate cancer progression. Nat. Cell Biol. 23(1), 87\u201398 (2021).","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"96683_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","volume":"3","author":"B Dong","year":"2020","unstructured":"Dong, B. et al. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer. Commun. Biol. 3(1), 778 (2020).","journal-title":"Commun. Biol."},{"issue":"11","key":"96683_CR12","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","volume":"39","author":"Y Kfoury","year":"2021","unstructured":"Kfoury, Y. et al. Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell 39(11), 1464-1478.e1468 (2021).","journal-title":"Cancer Cell"},{"issue":"7","key":"96683_CR13","doi-asserted-by":"publisher","first-page":"104576","DOI":"10.1016\/j.isci.2022.104576","volume":"25","author":"Z Wang","year":"2022","unstructured":"Wang, Z. et al. Single-cell transcriptional regulation and genetic evolution of neuroendocrine prostate cancer. iScience 25(7), 104576 (2022).","journal-title":"iScience"},{"issue":"28","key":"96683_CR14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2322203121","volume":"121","author":"S Zaidi","year":"2024","unstructured":"Zaidi, S. et al. Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies. Proc. Natl. Acad. Sci. U S A 121(28), e2322203121 (2024).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6611","key":"96683_CR15","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1126\/science.abn0478","volume":"377","author":"JM Chan","year":"2022","unstructured":"Chan, J. M. et al. Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377(6611), 1180\u20131191 (2022).","journal-title":"Science"},{"issue":"1","key":"96683_CR16","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/s41467-021-26042-z","volume":"12","author":"P Cejas","year":"2021","unstructured":"Cejas, P. et al. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer. Nat. Commun. 12(1), 5775 (2021).","journal-title":"Nat. Commun."},{"issue":"6","key":"96683_CR17","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20188746","volume":"15","author":"MD Luecken","year":"2019","unstructured":"Luecken, M. D. & Theis, F. J. Current best practices in single-cell RNA-seq analysis: A tutorial. Mol. Syst. Biol. 15(6), e8746 (2019).","journal-title":"Mol. Syst. Biol."},{"issue":"7938","key":"96683_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612(7938), 141\u2013147 (2022).","journal-title":"Nature"},{"issue":"3","key":"96683_CR19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41591-021-01244-6","volume":"27","author":"MX He","year":"2021","unstructured":"He, M. X. et al. Transcriptional mediators of treatment resistance in lethal prostate cancer. Nat. Med. 27(3), 426\u2013433 (2021).","journal-title":"Nat. Med."},{"issue":"12","key":"96683_CR20","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.ccell.2023.10.009","volume":"41","author":"CC Chen","year":"2023","unstructured":"Chen, C. C. et al. Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation. Cancer Cell 41(12), 2066-2082.e2069 (2023).","journal-title":"Cancer Cell"},{"issue":"6","key":"96683_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1093\/stmcls\/sxae025","volume":"42","author":"ML Beshiri","year":"2024","unstructured":"Beshiri, M. L. et al. Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate-resistant prostate cancer. Stem Cells 42(6), 526\u2013539 (2024).","journal-title":"Stem Cells"},{"key":"96683_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108955","author":"R Watanabe","year":"2023","unstructured":"Watanabe, R. et al. Spatial gene expression analysis reveals characteristic gene expression patterns of de novo neuroendocrine prostate cancer coexisting with androgen receptor pathway prostate cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24108955 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"96683_CR23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20(1), 296 (2019).","journal-title":"Genome Biol."},{"issue":"23","key":"96683_CR24","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.1073\/pnas.1902651116","volume":"116","author":"W Abida","year":"2019","unstructured":"Abida, W. et al. Genomic correlates of clinical outcome in advanced prostate cancer. Proc. Natl. Acad. Sci. U S A 116(23), 11428\u201311436 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"96683_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nm.4045","volume":"22","author":"H Beltran","year":"2016","unstructured":"Beltran, H. et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat. Med. 22(3), 298\u2013305 (2016).","journal-title":"Nat. Med."},{"issue":"10","key":"96683_CR26","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1158\/1078-0432.CCR-23-2438","volume":"30","author":"N Anselmino","year":"2024","unstructured":"Anselmino, N. et al. Integrative molecular analyses of the MD anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series. Clin. Cancer Res. 30(10), 2272\u20132285 (2024).","journal-title":"Clin. Cancer Res."},{"issue":"7406","key":"96683_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature11125","volume":"487","author":"CS Grasso","year":"2012","unstructured":"Grasso, C. S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487(7406), 239\u2013243 (2012).","journal-title":"Nature"},{"key":"96683_CR28","unstructured":"The Molecular Taxonomy of Primary Prostate Cancer. Cell 2015, 163(4):1011-1025."},{"issue":"3","key":"96683_CR29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.cell.2018.06.039","volume":"174","author":"DA Quigley","year":"2018","unstructured":"Quigley, D. A. et al. Genomic hallmarks and structural variation in metastatic prostate cancer. Cell 174(3), 758-769.e759 (2018).","journal-title":"Cell"},{"issue":"1","key":"96683_CR30","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1038\/s41467-021-26840-5","volume":"12","author":"M Bolis","year":"2021","unstructured":"Bolis, M. et al. Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression. Nat. Commun. 12(1), 7033 (2021).","journal-title":"Nat. Commun."},{"issue":"7801","key":"96683_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41586-020-2135-x","volume":"580","author":"J Li","year":"2020","unstructured":"Li, J. et al. A genomic and epigenomic atlas of prostate cancer in Asian populations. Nature 580(7801), 93\u201399 (2020).","journal-title":"Nature"},{"issue":"10","key":"96683_CR32","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1172\/JCI128212","volume":"129","author":"MP Labrecque","year":"2019","unstructured":"Labrecque, M. P. et al. Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. J. Clin. Invest. 129(10), 4492\u20134505 (2019).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"96683_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","volume":"18","author":"BS Taylor","year":"2010","unstructured":"Taylor, B. S. et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 18(1), 11\u201322 (2010).","journal-title":"Cancer Cell"},{"issue":"9","key":"96683_CR34","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ebiom.2015.07.017","volume":"2","author":"H Ross-Adams","year":"2015","unstructured":"Ross-Adams, H. et al. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. EBioMedicine 2(9), 1133\u20131144 (2015).","journal-title":"EBioMedicine"},{"issue":"12","key":"96683_CR35","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-13-2699","volume":"74","author":"Q Long","year":"2014","unstructured":"Long, Q. et al. Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Res. 74(12), 3228\u20133237 (2014).","journal-title":"Cancer Res."},{"issue":"9","key":"96683_CR36","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1158\/2159-8290.CD-21-0576","volume":"12","author":"S Linder","year":"2022","unstructured":"Linder, S. et al. Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer toward androgen independence. Cancer Discov. 12(9), 2074\u20132097 (2022).","journal-title":"Cancer Discov."},{"issue":"2","key":"96683_CR37","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00109-012-0949-1","volume":"91","author":"R Kuner","year":"2013","unstructured":"Kuner, R. et al. The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer. J. Mol. Med. (Berl.) 91(2), 237\u2013248 (2013).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"96683_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051122","author":"M Friedrich","year":"2020","unstructured":"Friedrich, M. et al. The role of lncRNAs TAPIR-1 and -2 as diagnostic markers and potential therapeutic targets in prostate cancer. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers12051122 (2020).","journal-title":"Cancers (Basel)"},{"issue":"14","key":"96683_CR39","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1158\/1078-0432.CCR-21-4289","volume":"28","author":"IM Coleman","year":"2022","unstructured":"Coleman, I. M. et al. Therapeutic implications for intrinsic phenotype classification of metastatic castration-resistant prostate cancer. Clin. Cancer Res. 28(14), 3127\u20133140 (2022).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"96683_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1158\/1078-0432.CCR-16-1245","volume":"23","author":"JA Sinnott","year":"2017","unstructured":"Sinnott, J. A. et al. Prognostic utility of a new mrna expression signature of gleason score. Clin. Cancer Res. 23(1), 81\u201387 (2017).","journal-title":"Clin. Cancer Res."},{"issue":"7637","key":"96683_CR41","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nature20788","volume":"541","author":"M Fraser","year":"2017","unstructured":"Fraser, M. et al. Genomic hallmarks of localized, nonindolent prostate cancer. Nature 541(7637), 359\u2013364 (2017).","journal-title":"Nature"},{"key":"96683_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129715","author":"MD Nyquist","year":"2019","unstructured":"Nyquist, M. D. et al. Molecular determinants of response to high-dose androgen therapy in prostate cancer. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.129715 (2019).","journal-title":"JCI Insight"},{"key":"96683_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032189","author":"MI Suominen","year":"2023","unstructured":"Suominen, M. I. et al. enhanced antitumor efficacy of radium-223 and enzalutamide in the intratibial LNCaP prostate cancer model. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24032189 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"96683_CR44","first-page":"202","volume":"2","author":"C Qian","year":"2023","unstructured":"Qian, C. et al. ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer. bioRxiv 2(3), 202 (2023).","journal-title":"bioRxiv"},{"issue":"1","key":"96683_CR45","doi-asserted-by":"publisher","first-page":"18227","DOI":"10.1038\/s41598-023-45199-9","volume":"13","author":"R Ruoff","year":"2023","unstructured":"Ruoff, R. et al. MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs. Sci. Rep. 13(1), 18227 (2023).","journal-title":"Sci. Rep."},{"key":"96683_CR46","doi-asserted-by":"publisher","first-page":"1210487","DOI":"10.3389\/fonc.2023.1210487","volume":"13","author":"RE White 3rd","year":"2023","unstructured":"White, R. E. 3rd. et al. Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPC. Front. Oncol. 13, 1210487 (2023).","journal-title":"Front. Oncol."},{"key":"96683_CR47","doi-asserted-by":"publisher","first-page":"1021845","DOI":"10.3389\/fonc.2022.1021845","volume":"12","author":"M Labaf","year":"2022","unstructured":"Labaf, M. et al. Increased AR expression in castration-resistant prostate cancer rapidly induces AR signaling reprogramming with the collaboration of EZH2. Front. Oncol. 12, 1021845 (2022).","journal-title":"Front. Oncol."},{"key":"96683_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122535","author":"S Verma","year":"2020","unstructured":"Verma, S., Shankar, E., Chan, E. R. & Gupta, S. Metabolic reprogramming and predominance of solute carrier genes during acquired enzalutamide resistance in prostate cancer. Cells https:\/\/doi.org\/10.3390\/cells9122535 (2020).","journal-title":"Cells"},{"issue":"10","key":"96683_CR49","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1172\/JCI127613","volume":"129","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee, P. et al. Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage. J. Clin. Invest. 129(10), 4245\u20134260 (2019).","journal-title":"J. Clin. Invest."},{"issue":"2","key":"96683_CR50","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.eururo.2004.09.007","volume":"47","author":"N Vashchenko","year":"2005","unstructured":"Vashchenko, N. & Abrahamsson, P. A. Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities. Eur. Urol. 47(2), 147\u2013155 (2005).","journal-title":"Eur. Urol."},{"issue":"4","key":"96683_CR51","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1158\/0008-5472.CAN-13-2921-T","volume":"74","author":"D Lin","year":"2014","unstructured":"Lin, D. et al. High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development. Cancer Res. 74(4), 1272\u20131283 (2014).","journal-title":"Cancer Res."},{"issue":"20","key":"96683_CR52","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1158\/1078-0432.CCR-15-0157","volume":"21","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. SRRM4 expression and the loss of REST activity may promote the emergence of the neuroendocrine phenotype in castration-resistant prostate cancer. Clin. Cancer Res. 21(20), 4698\u20134708 (2015).","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"96683_CR53","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari, A. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3(10), 1335\u20131342 (2017).","journal-title":"JAMA Oncol."},{"issue":"1","key":"96683_CR54","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1186\/s12885-017-3729-z","volume":"17","author":"HK Tsai","year":"2017","unstructured":"Tsai, H. K. et al. Gene expression signatures of neuroendocrine prostate cancer and primary small cell prostatic carcinoma. BMC Cancer 17(1), 759 (2017).","journal-title":"BMC Cancer"},{"issue":"4","key":"96683_CR55","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","volume":"32","author":"EG Bluemn","year":"2017","unstructured":"Bluemn, E. G. et al. Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling. Cancer Cell 32(4), 474-489.e476 (2017).","journal-title":"Cancer Cell"},{"issue":"12","key":"96683_CR56","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","volume":"25","author":"GH Henry","year":"2018","unstructured":"Henry, G. H. et al. A cellular anatomy of the normal adult human prostate and prostatic urethra. Cell Rep. 25(12), 3530-3542.e3535 (2018).","journal-title":"Cell Rep."},{"issue":"24","key":"96683_CR57","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","volume":"36","author":"R Aggarwal","year":"2018","unstructured":"Aggarwal, R. et al. Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: A multi-institutional prospective study. J. Clin. Oncol. 36(24), 2492\u20132503 (2018).","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"96683_CR58","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1002\/ijc.32430","volume":"145","author":"M Alshalalfa","year":"2019","unstructured":"Alshalalfa, M. et al. Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma. Int. J. Cancer 145(12), 3453\u20133461 (2019).","journal-title":"Int. J. Cancer"},{"issue":"5","key":"96683_CR59","first-page":"327","volume":"7","author":"S Cheng","year":"2019","unstructured":"Cheng, S. & Yu, X. Bioinformatics analyses of publicly available NEPCa datasets. Am. J. Clin. Exp. Urol. 7(5), 327\u2013340 (2019).","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"96683_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21031078","author":"P Ostano","year":"2020","unstructured":"Ostano, P. et al. Gene expression signature predictive of neuroendocrine transformation in prostate adenocarcinoma. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21031078 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"96683_CR61","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/2159-8290.CD-22-0692","volume":"13","author":"N De Sarkar","year":"2023","unstructured":"De Sarkar, N. et al. Nucleosome patterns in circulating tumor DNA reveal transcriptional regulation of advanced prostate cancer phenotypes. Cancer Discov. 13(3), 632\u2013653 (2023).","journal-title":"Cancer Discov."},{"issue":"3","key":"96683_CR62","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.7150\/thno.92336","volume":"14","author":"T Zhang","year":"2024","unstructured":"Zhang, T. et al. Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression. Theranostics 14(3), 1065\u20131080 (2024).","journal-title":"Theranostics"},{"key":"96683_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae471","author":"S Liu","year":"2024","unstructured":"Liu, S. et al. CDHu40: A novel marker gene set of neuroendocrine prostate cancer. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbae471 (2024).","journal-title":"Brief. Bioinform."},{"issue":"22","key":"96683_CR64","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1016\/j.cell.2024.09.044","volume":"187","author":"MC Kim","year":"2024","unstructured":"Kim, M. C. et al. Method of moments framework for differential expression analysis of single-cell RNA sequencing data. Cell 187(22), 6393-6410.e6316 (2024).","journal-title":"Cell"},{"key":"96683_CR65","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder, P. & Horvath, S. WGCNA: An R package for weighted correlation network analysis. BMC Bioinformatics 9, 559 (2008).","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"96683_CR66","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42(2), 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"96683_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2024.100910","author":"D Zeng","year":"2024","unstructured":"Zeng, D. et al. Enhancing immuno-oncology investigations through multidimensional decoding of tumor microenvironment with IOBR. Cell Rep. Methods https:\/\/doi.org\/10.1016\/j.crmeth.2024.100910 (2024).","journal-title":"Cell Rep. Methods"},{"key":"96683_CR68","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1016\/j.csbj.2024.06.035","volume":"23","author":"H Liu","year":"2024","unstructured":"Liu, H. et al. Mime: A flexible machine-learning framework to construct and visualize models for clinical characteristics prediction and feature selection. Comput. Struct. Biotechnol. J. 23, 2798\u20132810 (2024).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"96683_CR69","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf6123","author":"J Reddy","year":"2021","unstructured":"Reddy, J. et al. Predicting master transcription factors from pan-cancer expression data. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abf6123 (2021).","journal-title":"Sci. Adv."},{"key":"96683_CR70","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","author":"CJ Liu","year":"2023","unstructured":"Liu, C. J. et al. GSCA: An integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbac558 (2023).","journal-title":"Brief. Bioinform."},{"issue":"8","key":"96683_CR71","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt, J., Santos-Martins, D., Tillack, A. F. & Forli, S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and python bindings. J. Chem. Inf. Model 61(8), 3891\u20133898 (2021).","journal-title":"J. Chem. Inf. Model"},{"issue":"5","key":"96683_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese, F., Bukhari, A. B., Malhotra, R. & De, A. IHC Profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE 9(5), e96801 (2014).","journal-title":"PLoS ONE"},{"issue":"22","key":"96683_CR73","doi-asserted-by":"publisher","first-page":"12315","DOI":"10.1073\/pnas.1922207117","volume":"117","author":"JJ Alumkal","year":"2020","unstructured":"Alumkal, J. J. et al. Transcriptional profiling identifies an androgen receptor activity-low, stemness program associated with enzalutamide resistance. Proc. Natl. Acad. Sci. U S A 117(22), 12315\u201312323 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"17","key":"96683_CR74","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1158\/1078-0432.CCR-20-4968","volume":"27","author":"DH Kim","year":"2021","unstructured":"Kim, D. H. et al. BET bromodomain inhibition blocks an AR-Repressed, E2F1-Activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program. Clin. Cancer Res. 27(17), 4923\u20134936 (2021).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"96683_CR75","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/thno.96163","volume":"14","author":"ZJ Gao","year":"2024","unstructured":"Gao, Z. J. et al. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype. Theranostics 14(8), 3104\u20133126 (2024).","journal-title":"Theranostics"},{"key":"96683_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00855-5","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Single-cell transcriptomic landscape deciphers olfactory neuroblastoma subtypes and intratumoral heterogeneity. Nat. Cancer https:\/\/doi.org\/10.1038\/s43018-024-00855-5 (2024).","journal-title":"Nat. Cancer"},{"issue":"1","key":"96683_CR77","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-024-02062-3","volume":"23","author":"DZ Guo","year":"2024","unstructured":"Guo, D. Z. et al. Single-cell tumor heterogeneity landscape of hepatocellular carcinoma: Unraveling the pro-metastatic subtype and its interaction loop with fibroblasts. Mol. Cancer 23(1), 157 (2024).","journal-title":"Mol. Cancer"},{"issue":"6","key":"96683_CR78","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ccell.2024.05.002","volume":"42","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators. Cancer Cell 42(6), 1106-1125.e1108 (2024).","journal-title":"Cancer Cell"},{"issue":"12","key":"96683_CR79","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jtho.2020.09.009","volume":"15","author":"MK Baine","year":"2020","unstructured":"Baine, M. K. et al. SCLC subtypes defined by ASCL1, NEUROD1, POU2F3, and YAP1: A comprehensive immunohistochemical and histopathologic characterization. J. Thorac. Oncol. 15(12), 1823\u20131835 (2020).","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"96683_CR80","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41467-018-08133-6","volume":"10","author":"H Guo","year":"2019","unstructured":"Guo, H. et al. ONECUT2 is a driver of neuroendocrine prostate cancer. Nat. Commun. 10(1), 278 (2019).","journal-title":"Nat. Commun."},{"issue":"3","key":"96683_CR81","doi-asserted-by":"publisher","first-page":"108","DOI":"10.31083\/j.fbl2703108","volume":"27","author":"H Kawai","year":"2022","unstructured":"Kawai, H., Matsuoka, R., Ito, T. & Matsubara, D. Molecular subtypes of high-grade neuroendocrine carcinoma (HGNEC): What is YAP1-Positive HGNEC?. Front. Biosci. (Landmark Ed) 27(3), 108 (2022).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"96683_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2021.01.024","volume":"503","author":"Y Liu","year":"2021","unstructured":"Liu, Y. et al. In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation. Cancer Lett. 503, 163\u2013173 (2021).","journal-title":"Cancer Lett."},{"issue":"1","key":"96683_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/path.6363","volume":"265","author":"Y Yong","year":"2025","unstructured":"Yong, Y. et al. AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrine active tumorigenic secretomes. J. Pathol. 265(1), 14\u201325 (2025).","journal-title":"J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96683-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96683-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T08:02:16Z","timestamp":1745308936000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96683-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96683"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96683-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors have approved the manuscript and agree with its submission.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patient specimens were collected in accordance with ethical standards set forth in the Declaration of Helsinki, and written informed consent was obtained from all participants. The study was approved by the Ethics Committee of the Fourth Affiliated Hospital of Zhejiang University Medical College, Yiwu, Zhejiang, China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"13901"}}